Proactively supporting experts in risk communication can help avert situation in which the public might actually reject the technology due to unexplained fears and worries, he said. This perceived difficulty is attributed to the fact that manufacturing standards for nanomaterials and components are yet to evolve. Concerns about the potential ill effects of engineered nanomaterials such as carbon buckyballs and nanotubes through inhalation, ingestion, or absorption through the skin are increasing. It important to gather the views of all stakeholders in order to help prepare effective and efficient future initiatives at European level, said Busquin.

Among the ECs proposals are doubling in funding for the sector in its next research budget in 2006.Europe must build upon the solid knowledge base that it has developed through research in nanosciences and nanotechnologies and translate this into useful and commercially viable products and services, commented Philippe Busquin, the European Research Commissioner.At the same time we must play proactive role for ensuring its safe and responsible development and use, also at global level, European Research Commissioner Philippe Busquin said. It is expected to have applications in broad range of industries, but there are nearterm, tangible uses in pharmaceuticals and medicine.

Nanotechnology also faces strong challenge in the shape of negative public perceptions with growing reports about the possible toxic effects of exposure to nanoparticles. But Europe is investing proportionately less than its main competitors, according to the Commission. An EUfunded network called Nanoforum has been created to serve as forum for ideas, and has set up an online questionnaire. The EU has an excellent knowledge base, with per cent of international nanotechnology publications in 19971999, compared to per cent in Japan. By using preventive medicine, treatment for diseases could be initiated even before preliminary symptoms appear.

While the European Union is at the forefront of research into nanotechnology, this position is in danger of being eroded, with both the US and per cent in Japan. For example, in earlystage studies it has been shown that inhaled nanosized particles accumulate in the nasal cavities, lungs and brains of rats, raising concerns that this buildup could lead to harmful inflammation and risk of brain damage or other central nervous system disorders.